he Center for Biopharma Analysis (CBA) supported by the National Biopharma Mission (NBM) of Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) at Pune-based technology business incubator, venture center was inaugurated recently.
Center for Biopharma Analysis
CBA will provide high-quality analytical services for biopharmaceutical developers and manufacturers. This center is envisioned to become a resource center for structural and functional characterization of biologicals and biopharmaceuticals that will create long lasting value for bioentrepreneurs and industry. The CBA will play a pivotal role in supporting biopharma innovations from academic and government research labs, startups and many Indian companies with not only high-quality analytical characterization but also advise on studies needed for regulatory approvals. This can help speed up the development process.
About Venture Center: Entrepreneurship Development Center (Venture Center) – a CSIR initiative – is a section 25 company hosted by the National Chemical Laboratory, Pune. Venture Center strives to nucleate and nurture technology and knowledge based enterprises by leveraging the scientific and engineering competencies of the institutions in the Pune region in India. The Venture Center is a technology business incubator supported by the Department of Science & Technology’s National Science & Technology Entrepreneurship Development Board (DST-NSTEDB). Venture Center focuses on technology enterprises offering products and services exploiting scientific expertise in the areas of materials, chemicals and biological sciences & engineering.
About CBA: Center for BioPharma Analysis (CBA) is an initiative of Venture Center supported by the National BioPharma Mission, BIRAC (Government of India). The Venture Center is a technology business incubator hosted by CSIR-National Chemical Laboratory, Pune. It is a state-of-the-art facility with high-end instrumentation and industry-linked personnel providing globally acceptable analysis of biopharmaceuticals. It provides open access cutting-edge technologies for biopharmaceutical analysis and would emerge as a resource center for characterization of biopharmaceuticals. The facility aims to cater all academics, small to medium size biosimilar developers through-out India and the world.